×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [24]
内容类型
期刊论文 [24]
发表日期
2022 [7]
2021 [9]
2020 [5]
2018 [1]
2015 [1]
2011 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共24条,第1-10条
帮助
限定条件
专题:合肥物质科学研究院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial
期刊论文
BRITISH JOURNAL OF CANCER, 2022
作者:
Qin, Shukui
;
Li, Jin
;
Zhong, Haijun
;
Jin, Chuan
;
Chen, Lili
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2022/12/22
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
期刊论文
THORACIC CANCER, 2022
作者:
Xu, Chunwei
;
Si, Lu
;
Wang, Wenxian
;
Li, Ziming
;
Song, Zhengbo
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2022/12/22
fusion
precision medicine
solid tumor
targeted therapy
tyrosine receptor kinase
Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
期刊论文
PHARMACEUTICS, 2022, 卷号: 14
作者:
Ji, Qing
;
Wu, Yuchen
;
Albers, Andreas
;
Fang, Meiyu
;
Qian, Xu
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2022/12/22
oncolytic viruses
nanotechnology
oncolytic virotherapy
immunotherapy
melanoma
head and neck cancer
First-in-human, phase I study of AK109, an anti-VEGFR2 antibody, in patients (pts) with advanced or metastatic solid tumors.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Xu, Nong
;
Zheng, Yulong
;
Zhong, Haijun
;
Zhao, Fuyou
;
Zhou, Huan
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2022/12/23
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study
期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:
Wang, Wenxian
;
Shao, Lan
;
Xu, Yibing
;
Song, Zhengbo
;
Lou, Guangyuan
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2022/12/23
Non-small cell lung cancer
Prognosis
Angiogenesis
Tyrosine kinase inhibitors
Efficacy and safety of radiotherapy combined with raltitrexed and irinotecan for treating unresectable recurrent colorectal cancer: a single-arm phase II trial
期刊论文
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022
作者:
Li, Xinghui
;
Shen, Jinwen
;
Xia, Fan
;
Zhu, Ji
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2022/12/23
Colorectal cancer
local recurrence
intensity-modulated radiotherapy
irinotecan
raltitrexed
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial
期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022
作者:
Liu, Jihong
;
Yin, Rutie
;
Wu, Lingying
;
Zhu, Jianqing
;
Lou, Ge
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2022/05/05
BRCA mutation
China
olaparib
ovarian cancer
PARP inhibitor
Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world study
期刊论文
CANCER CELL INTERNATIONAL, 2021, 卷号: 21
作者:
Jin, Ya-Nan
;
Qiang, Meng-Yun
;
Liu, Meng-Meng
;
Cheng, Zhi-Bin
;
Zhang, Wang-Jian
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2022/01/10
Nasopharyngeal carcinoma
Cumulative cisplatin dose
Children and adolescents
Tumor response
Neoadjuvant chemotherapy
Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers
期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 卷号: 9
作者:
Ying, Jieer
;
Yang, Lin
;
Yin, Jiani C.
;
Xia, Guojie
;
Xing, Minyan
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2021/11/15
biomarkers
tumor
genetic markers
genome instability
Immunotherapy
translational medical research
Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
期刊论文
CELL DEATH & DISEASE, 2021, 卷号: 12
作者:
Liu, Dongyan
;
Hou, Xiaonan
;
Wu, Wangyu
;
Zafagnin, Valentina
;
Li, Yunjian
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2021/09/06
©版权所有 ©2017 CSpace - Powered by
CSpace